QUANTUM X LABS INC. QXL
Nasdaq · XNAS · stock · Services-Prepackaged Software
Chart by TradingView
1/9
Piotroski F — financial health
-15.88
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | — | -$19.3M | — | — | $5.0M |
| 2024 | $26.9M | -$12.1M | — | $1.4M | $7.5M |
| 2023 | $79.6M | -$7.3M | — | $918,000 | $18.6M |
| 2022 | $96.6M | $28,000 | — | $3.2M | $29.9M |
| 2021 | $45.2M | $300,000 | $41,000 | $4.1M | $18.5M |
| 2020 | $96,000 | -$443,000 | $91,000 | — | $13.3M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Yoresh Eliyahu | director | 2026-05-31 | Option exercise | 88,675 | $0.00 |
| Baranes Yakov | Co-CEO | 2026-05-31 | Option exercise | 246,387 | $0.00 |
| Weiss Amitay | director | 2026-03-31 | Sell | 30,296 | $2.00 |
| Yoresh Eliyahu | director | 2026-03-04 | Buy | 179,159 | — |
| Yoresh Eliyahu | director | 2025-09-03 | Buy | 260,000 | $1.00 |
| Yoresh Eliyahu | director | 2025-09-03 | Gift | 100,000 | — |
| Yoresh Eliyahu | director | 2025-07-11 | Buy | 5,144 | $4.86 |
| Yoresh Eliyahu | director | 2025-06-17 | Gift | 405 | — |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -15.88 (distress)
- Working capital / assets -0.224
- Retained earnings / assets -4.281
- EBIT / assets -0.203
- Equity / liabilities 0.865
Source: SEC EDGAR filings · CIK 0000797542 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.